| Treatments | Hypertrophy Markers(% of control) | Apoptosis Markers (% of control) | |||
| Total protein/cell No. | ANP mRNA | α-sk actin mRNA | Caspase 3/7 Activity | Viable cell number | |
| rhCTGF (500 ng/mL) | 183 ± 22* | 145 ± 16* | 129 ± 10* | 179 ± 12* | 79 ± 8* |
| Glucose (30 mM) | 148 ± 24* | 340 ± 43* | 201 ± 27* | 228 ± 5.0* | 79 ± 2* |
| Palmitate (50 μM) | 165 ± 29* | 161 ± 23* | 155 ± 18* | 192 ± 19* | 68 ± 5* |
| Palmitate (100 μM) | 397 ± 7.0* | 143 ± 24 | 189 ± 39* | 262 ± 49* | 53 ± 5* |
| Glucose (30 mM) + CTGF SiRNA | 114 ± 16+ | ND | ND | 156.3 ± 17+ | 88 ± 8+ |
| Palmitate (50 μM) + CTGF SiRNA | 107 ± 1.8+ | ND | ND | 123.5 ± 35+ | 98 ± 7+ |